| Serial Number | 79175425 |
| Word Mark | D |
| Filing Date | Monday, December 29, 2014 |
| Status | 709 - CANCELLED - SECTION 71 |
| Status Date | Friday, April 12, 2024 |
| Registration Number | 5293323 |
| Registration Date | Tuesday, September 26, 2017 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, November 8, 2016 |
| Goods and Services | Entertainment television news programme services in the field of pharmaceutical products and sanitary preparations for medical purposes broadcast over the internet; organizing community festivals featuring primarily pharmaceutical exhibition for medical purposes; arranging professional workshop and training courses in the field of pharmaceutical products and medicine for medical purposes; training services in the field of pharmaceutical and sanitary preparations for medical purposes; education service, namely, providing tutoring in the field of pharmaceutical and sanitary preparations for medical purposes; providing information relating to organizing community cultural activities and contests |
| Description of Mark | The mark consists of a letter "D" within a hexagon. |
| Goods and Services | Pharmaceutical preparation for the treatment of respiratory diseases; pharmaceutical preparation for the treatment of bone diseases; analgesic and muscle relaxant pharmaceutical preparations; antibacterial pharmaceuticals; anti-epileptic pharmaceutical preparations; balms for pharmaceutical purposes; capsules sold empty for pharmaceuticals; cardiovascular pharmaceuticals; gelatin capsules sold empty for pharmaceuticals; ocular pharmaceuticals; pharmaceutical products for ophthalmological use; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases also rare; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases; pharmaceutical antitussive cold pharmaceutical preparations for use in chemotherapy; pharmaceutical products for the treatment of viral and infectious diseases; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in tissue and organ transplantation also rare; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations, namely, anticoagulants; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for peripheral nervous system; pharmaceutical preparations for treating diabetes also rare; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for the treatment of bacteria-based diseases, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations, namely, an analgesic for human consumption taken orally; sanitary preparations for medical purposes; all-purpose disinfectants |
| Pseudo Mark | DOMPE |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Conducting early evaluations in the field of new pharmaceuticals; conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology, treatment of cancer, diabetes, analgesic preparations, nerve grow factors, oncology, organ transplantation, antibiotics, respiratory diseases, bone diseases, rare diseases; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, medical diagnostics, drug development and pharmacogenetics; development of pharmaceutical preparations and medicines; laboratory research services relating to pharmaceuticals; research and development of pharmaceuticals for the treatment of cancer, diabetes, respiratory diseases, bone diseases, rare diseases, ocular disorders and diseases; research and development in the pharmaceutical and biotechnology fields |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, April 12, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, April 12, 2024 |
| Primary Code | 041 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, April 12, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | DOMPE' FARMACEUTICI S.P.A. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 09 - Joint Stock Company |
| Address | IT |
| Party Name | DOMPE' FARMACEUTICI S.P.A. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 09 - Joint Stock Company |
| Address | IT |
| Party Name | DOMPE' FARMACEUTICI S.P.A. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 09 - Joint Stock Company |
| Address | IT |
| Event Date | Event Description |
| Tuesday, December 1, 2015 | REFUSAL PROCESSED BY MPU |
| Friday, November 6, 2015 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Tuesday, November 10, 2015 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Thursday, November 12, 2015 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, November 12, 2015 | ASSIGNED TO EXAMINER |
| Thursday, November 12, 2015 | ASSIGNED TO EXAMINER |
| Tuesday, November 17, 2015 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, November 25, 2015 | NON-FINAL ACTION WRITTEN |
| Thursday, November 26, 2015 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, September 28, 2016 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Tuesday, December 1, 2015 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, December 18, 2015 | REFUSAL PROCESSED BY IB |
| Thursday, April 28, 2016 | NEW REPRESENTATIVE AT IB RECEIVED |
| Wednesday, June 1, 2016 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, June 1, 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, June 2, 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, June 30, 2016 | FINAL REFUSAL WRITTEN |
| Thursday, June 30, 2016 | FINAL REFUSAL E-MAILED |
| Thursday, June 30, 2016 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Wednesday, December 7, 2016 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Wednesday, September 28, 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, September 28, 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, September 28, 2016 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, October 19, 2016 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, October 19, 2016 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, October 19, 2016 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Tuesday, November 8, 2016 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 8, 2016 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Friday, November 18, 2016 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Monday, August 21, 2017 | OPPOSITION DISMISSED NO. 999999 |
| Monday, August 21, 2017 | TTAB RELEASE CASE TO TRADEMARKS |
| Wednesday, April 5, 2017 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Wednesday, April 5, 2017 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Tuesday, May 9, 2017 | OPPOSITION NOTICE (IB REFUSAL) CREATED |
| Tuesday, May 9, 2017 | OPPOSITION NOTICE (IB REFUSAL) SENT TO IB |
| Wednesday, May 10, 2017 | OPPOSITION INSTITUTED NO. 999999 |
| Friday, May 12, 2017 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Saturday, June 3, 2017 | REFUSAL PROCESSED BY IB |
| Monday, August 21, 2017 | OPPOSITION TERMINATED NO. 999999 |
| Friday, June 4, 2021 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Friday, April 12, 2024 | CANCELLED SECTION 71 |
| Tuesday, September 26, 2017 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, December 26, 2017 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Friday, December 29, 2017 | FINAL DISPOSITION PROCESSED |
| Friday, December 29, 2017 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, January 26, 2018 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Friday, February 12, 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
| Monday, September 26, 2022 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| Friday, December 13, 2024 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
| Friday, February 14, 2025 | TOTAL INVALIDATION PROCESSED BY THE IB |
| Sunday, January 19, 2025 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| Sunday, January 19, 2025 | INVALIDATION PROCESSED |